Molecular mechanism of vasculogenic mimicry in brain glioma

doi:10.3760/cma.j.cn371439-20200617-00069

Abstract

Abstract:

Vasculogenic mimicry (VM) is a new tumor angiogenesis mode independent of endothelial cells and an important component of tumor microcirculation. The formation mechanism of VM in glioma is complex and variable. Various molecules and signal pathways (such as hypoxia induction factor and matrix metalloproteasefamily) interact in the formation process, to jointly regulate the formation of VM. The in-depth study of molecular mechanism can provide a theoretical basis for drug research and development against VM formation.

Key words: Glioma, Vasculogenic mimicry, Molecular mechanisms

Guo Shihao, Ren Yeqing, Guo Geng. Molecular mechanism of vasculogenic mimicry in brain glioma[J]. Journal of International Oncology, 2021, 48(6): 362-365.

References 33

[1]	Wen PY, Reardon DA. Neuro-oncology in 2015: progress in glioma diagnosis, classification and treatment[J]. Nat Rev Neurol, 2016,12(2):69-70. DOI: 10.1038/nrneurol.2015.242.
[2]	Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vaseulogenie mimicry[J]. Am J Pathol, 1999,155(3):739-752. DOI: 10.1016/S0002-9440(10)65173-5. pmid: 10487832
[3]	白驹, 徐志杰, 廖朝亮 , 等. 血管形成拟态在肿瘤中的研究进展[J]. 中南大学学报(医学版), 2017,42(3):357-364. DOI: 10.11817/j.issn.1672-7347.2017.03.020.
[4]	Zhang X, Zhang J, Zhou H, et al. Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry[J]. J Cancer, 2019,10(25):6327-6340. DOI: 10.7150/jca.34171. doi: 10.7150/jca.34171 pmid: 31772665
[5]	Ge H, Luo H. Overview of advances in vasculogenic mimicry—a potential target for tumor therapy[J]. Cancer Manag Res, 2018,10:2429-2437. DOI: 10.2147/CMAR.S164675. doi: 10.2147/CMAR
[6]	El Hallani S, Boisselier B, Peglion F, et al. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry[J]. Brain, 2010,133(Pt 4):973-982. DOI: 10.1093/brain/awq044. doi: 10.1093/brain/awq044
[7]	Sun W, Fan YZ, Zhang WZ, et al. A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro[J]. J Exp Clin Cancer Res, 2011,30(1):46. DOI: 10.1186/1756-9966-30-46. doi: 10.1186/1756-9966-30-46
[8]	Williamson SC, Metcalf RL, Trapani F, et al. Vasculogenic mimicry in small cell lung cancer[J]. Nat Commu, 2016,7:13322. DOI: 10.1038/ncomms13322.
[9]	Angara K, Rashid MH, Shankar A, et al. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies[J]. Histol Histopathol, 2017,32(9):917-928. DOI: 10.14670/HH-11-856.
[10]	Yang J, Zhu DM, Zhou XG, et al. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter[J]. Oncotarget, 2017,8(29):47801-47815. DOI: 10.18632/oncotarget.17999. doi: 10.18632/oncotarget.v8i29
[11]	Li J, Ke Y, Huang S, et al. Inhibitory effects of B-cell lymphoma 2 on the vasculogenic mimicry of hypoxic human glioma cells[J]. ExTher Med, 2015,9(3):977-981. DOI: 10.3892/etm.2014.2162.
[12]	Guo X, Xu S, Gao X, et al. Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells[J]. Oncotarget, 2017,8(46):80358-80372. DOI: 10.18632/oncotarget.18673. doi: 10.18632/oncotarget.v8i46
[13]	Zhu Y, Liu X, Zhao P, et al. Celastrol suppresses glioma vasculogenic mimicry formation and angiogenesis by blocking the PI3K/Akt/mTOR signaling pathway[J]. Front Pharmacol, 2020,11:25. DOI: 10.3389/fphar.2020.00025. doi: 10.3389/fphar.2020.00025
[14]	Li X, Xue Y, Liu X, et al. ZRANB2/SNHG20/FOXK1 Axis regulates vasculogenic mimicry formation in glioma[J]. J Exp Clin Can-cer Res, 2019,38(1):68. DOI: 10.1186/s13046-019-1073-7.
[15]	Delgado-Bellido D, Serrano-Saenz S, Fernández-Cortés M, et al. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin[J]. Mol Cancer, 2017,16(1):65. DOI: 10.1186/s12943-017-0631-x. doi: 10.1186/s12943-017-0631-x pmid: 28320399
[16]	Liu S, Zhang SM, Ju RJ, et al. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma[J]. Eur J Phar Sci, 2017,106:185-197. DOI: 10.1016/j.ejps.2017.06.002.
[17]	Liu X, Wang JH, Li S, et al. Histone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide 3-kinase/ERK-MMP-laminin5γ2 signaling pathway[J]. Cancer Sci, 2015,106(7):857-866. DOI: 10.1111/cas.12684. doi: 10.1111/cas.2015.106.issue-7
[18]	Guo J, Cai H, Liu X, et al. Long non-coding RNA LINC00339 stimulates glioma vasculogenic mimicry formation by regulating the miR-539-5p/TWIST1/MMPs axis[J]. Mol Ther Nucleic Acids, 2018,10:170-186. DOI: 10.1016/j.omtn.2017.11.011. doi: 10.1016/j.omtn.2017.11.011
[19]	Zhang L, Xu Y, Sun J, et al. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expre-ssion in glioma cells[J]. Oncotarget, 2017,8(1):819-832. DOI: 10.18632/oncotarget.13661. doi: 10.18632/oncotarget.13661 pmid: 27903982
[20]	Yu W, Ding J, He M, et al. Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer[J]. Oncogene, 2019,38(8):1225-1238. DOI: 10.1038/s41388-018-0463-1. doi: 10.1038/s41388-018-0463-1
[21]	Li G, Huang M, Cai Y, et al. miR-141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression[J]. Mol Med Rep, 2018,18(2):1395-1404. DOI: 10.3892/mmr.2018.9108.
[22]	Gao Y, Yu H, Liu Y, et al. Long non-coding RNA HOXA-AS2 regulates malignant glioma behaviors and vasculogenic mimicry formation via the MiR-373/EGFR axis[J]. Cell Physiol Biochem, 2018,45(1):131-147. DOI: 10.1159/000486253. doi: 10.1159/000486253
[23]	Wang D, Zheng J, Liu X, et al. Knockdown of USF1 inhibits the vasculogenic mimicry of glioma cells via stimulating SNHG16/miR-212-3p and linc00667/miR-429 axis[J]. Mol Ther Nucleic Acids, 2019,14:465-482. DOI: 10.1016/j.omtn.2018.12.017. doi: 10.1016/j.omtn.2018.12.017
[24]	Yang J, Lu Y, Lin YY, et al. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associatedfibroblasts and inhibited by miR-101 in hepatocellular carcinoma[J]. Cancer Lett, 2016,383(1):18-27. DOI: 10.1016/j.canlet.2016.09.012. doi: 10.1016/j.canlet.2016.09.012
[25]	Ling G, Wang S, Song Z, et al. Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG[J]. Cancer Biol Ther, 2011,12(11):978-988. DOI: 10.4161/cbt.12.11.18155. doi: 10.4161/cbt.12.11.18155
[26]	Ling G, Ji Q, Ye W, et al. Epithelial-mesenchymal transition regulated by p38/MAPK signaling pathways participates in vasculogenic mimicry formation in SHG44 cells transfected with TGF-β cDNA loaded lentivirus in vitro and in vivo[J]. Int J Oncol, 2016,49(6):2387-2398. DOI: 10.3892/ijo.2016.3724. doi: 10.3892/ijo.2016.3724
[27]	Zhang C, Chen WL, Zhang X, et al. Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes[J]. Sci Rep, 2016,6:23056. DOI: 10.1038/srep23056. doi: 10.1038/srep23056
[28]	Cai HP, Wang J, Xi SY, et al. Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma[J]. Cell Death Dis, 2019,10(12):879. DOI: 10.1038/s41419-019-2102-3. doi: 10.1038/s41419-019-2102-3
[29]	Liu Y, Li F, Yang YT, et al. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma[J]. Oncogene, 2019,38(11):1815-1831. DOI: 10.1038/s41388-018-0525-4. doi: 10.1038/s41388-018-0525-4 pmid: 30368528
[30]	Zhang F, Chu J, Wang F. Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas[J]. Oncol Lett, 2017,14(2):1303-1308. DOI: 10.3892/ol.2017.6281. doi: 10.3892/ol.2017.6281 pmid: 28789345
[31]	Rong X, Huang B, Qiu S, et al. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation[J]. Oncotarget, 2016,7(51):83976-83986. DOI: 10.18632/oncotarget.6930. doi: 10.18632/oncotarget.v7i51
[32]	Ju RJ, Zeng F, Liu L, et al. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma[J]. Int J Nanomedicine, 2016,11:1131-1146. DOI: 10.2147/IJN.S94467.
[33]	Huang M, Ke Y, Sun X, et al. Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1α[J]. Oncol Rep, 2014,32(5):1973-1980. DOI: 10.3892/or.2014.3454. doi: 10.3892/or.2014.3454